| EKWCX | FGADX | EKWCX / FGADX | |
| Total Expense Ratio | 1.84 | 0.62 | 297% |
| Annual Report Gross Expense Ratio | 1.91 | 0.62 | 308% |
| Fund Existence | 29 years | 30 years | - |
| Gain YTD | 20.052 | 19.242 | 104% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 1.47B | 3.71B | 40% |
| Annual Yield % from dividends | 0.55 | 11.18 | 5% |
| Returns for 1 year | 77.53 | 97.01 | 80% |
| Returns for 3 years | 315.91 | 359.13 | 88% |
| Returns for 5 years | 288.70 | 273.12 | 106% |
| Returns for 10 years | 275.90 | 316.24 | 87% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| PZVEX | 17.58 | 0.23 | +1.33% |
| Pzena Emerging Markets Value Investor | |||
| WPVIX | 32.50 | 0.26 | +0.81% |
| Weitz Multi Cap Equity-Institutional Cl | |||
| GTTUX | 75.28 | 0.44 | +0.59% |
| Goldman Sachs Small Cp Val Insghts R6 | |||
| JLGMX | 88.44 | 0.47 | +0.53% |
| JPMorgan Large Cap Growth R6 | |||
| WSBFX | 24.80 | 0.08 | +0.32% |
| Boston Trust Walden Balanced | |||